exploring innovations in healthcare
I wanted to highlight a list of books, conferences and courses that I derived value from over the last 12 months. Books Bad Blood — John Carreyrou Bad Blood provides the reader with an in-depth analysis of the failed-start-up company Theranos. Built upon a complex...
The inherited cardiac condition team As part of my DPhil I have been fortunate to work closely with a team of experts that diagnose and manage individuals, and families, affected by inherited cardiac conditions. Hypertrophic cardiomyopathy The most common inherited cardiac condition is hypertrophic cardiomyopathy....
What is the scope for blockchain technologies? “There is technology becoming available … I don’t claim to be an expert on it but the most obvious technology is blockchain” boasted Chancellor Philip Hammond at the Conservative Party Conference, when discussing the Irish border challenges of Brexit....
Over the last few days I was fortunate enough to attend the Royal Society’s conference on “Delivering novel therapies in the 21st century” and have summarised a few of the key themes: – Big Picture Lots of high-level statements were presented at the meeting, but...
This past week I attended Nvidia’s GPU Technology Conference (GTC) where I learnt more about the disruptive force of artificial intelligence within society. Whilst it is easy to get distracted by the many exhibitions highlighting broad applications of artificial intelligence, I focussed on the intersection between...
My daily Twitter use is often spontaneous and sporadic. I tend to read more than I post. It occupies the brief voids one encounters during the day, ably distracts, and provides an unparalleled source of education. I tend to latch onto a single theme per day...
A loss-of-function genetic variant that protects against chronic liver disease was reported in the The New England Journal of Medicine on 22nd March 2018. This finding adds to a series of previously established protective variants and appears to have stimulated efforts to advance treatment options...
Our perspective on remote monitoring for heart failure @ProfMartinCowie @escardio #digitalhealth https://t.co/u83AwDzlIB — Andrew Harper (@DrAndrewHarper) March 2, 2017
Clinical information has low sensitivity for postmortem diagnosis of heart valve disease @DrSeanCoffey @bj_cairns https://t.co/VCVaXrEhwK — Andrew Harper (@DrAndrewHarper) February 12, 2017 The OxVALVE study group, led by Dr Bernard Prendergast (Oxford Valvular Heart Disease Population Study) group was established in 2009 to determine whether the...
Yesterday I hosted the 4th annual Recent Developments in Digital Health conference at the Royal Society of Medicine. This was the 3rd year I organised and chaired the event. It is a real pleasure to run these events and provide members of the healthcare community with...